Literature DB >> 235374

Modulation by prostaglandins of adrenergic transmission in the isolated perfused rabbit and rat kidney.

K U Malik, J C McGiff.   

Abstract

In the isolated perfused rabbit kidney prostaglandins (PGS) E1 (0.02-0-1 ng/ml), E2 (0.02-0.1 ng/ml), and A2 (1-5 ng/ml) inhibited the vasoconstrictor responses to sympathetic nerve stimulation by 21-44%, 31-39%, and 20-23%, respectively, without alerting those to injected norepinephrine. In contrast, in the rat kidney PGE1 (0.5 ng/ml), PGE2 (0.5 ng/ml), and PGA2 (5 ng/ml) enhanced the vasoconstrictor responses to sympathetic nerve stimulation by 41%, 27%, and 11%, respectively; the equiconstrictor responses to injected norepinephrine remained unaltered. Higher concentrations of these agents produced vasodilation in the rabbit kidney and vasoconstriction in the rat kidney. In both species PGF2alpha produced vasoconstriction and enhanced the response to both adrenergic stumuli. In the rabbit kidney inhibitors of PG synthesis augmented the responses to sympathetic nerve stimulation without altering those to injected norepinephrine, whereas in the rat kidney inhibition of the responses to both adrenergic stimuli occurred. Arachidonic acid inhibited the vasoconstrictor responses to sympathetic nerve stimulation in the rabbit kidney, but in the rat kidney it caused augmentation of these responses. Since these effects of arachidonic acid were reduced by indomethacin, they appear to be mediated through the acid's conversion to PGS. We conclude that PGS of the E series modulate adrenergic transmission in the kidney and that their modulatory actions are species dependent.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 235374     DOI: 10.1161/01.res.36.5.599

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  32 in total

1.  Proceedings: Possible contribution of prostaglandins to genetic hypertension in rats: identification of biochemical lesion.

Authors:  J M Armstrong; G J Blackwell; R J Flower; J C McGiff; K Mullane
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.

Authors:  J Quilley; J C McGiff; A Nasjletti
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

3.  The vasodilator action of parathyroid hormone fragments on isolated perfused rat kidney.

Authors:  M J Musso; M Barthelmebs; J L Imbs; M Plante; C Bollack; J J Helwig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-08       Impact factor: 3.000

4.  Kallistatin is a potent new vasodilator.

Authors:  J Chao; J N Stallone; Y M Liang; L M Chen; D Z Wang; L Chao
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

5.  The influence of prostaglandins on noradrenaline-induced vasoconstriction isolated perfused mesenteric blood vessels of the rat.

Authors:  I M Coupar; P L McLennan
Journal:  Br J Pharmacol       Date:  1978-01       Impact factor: 8.739

6.  Renal vasodilator activity of prostaglandin E2 in the rat anaesthetized with pentobarbitone.

Authors:  J Haylor; J Towers
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

7.  Inhibitory action of bradykinin on release of the adrenergic transmitter in the isolated lapine kidney.

Authors:  K U Malik; A Nasjletti
Journal:  Experientia       Date:  1981-05-15

8.  Renal prostaglandin synthesis in the spontaneously hypertensive rat.

Authors:  M J Dunn
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

9.  Renal function and renal venous prostaglandin concentrations during different stages of experimental renal hypertension in the rat.

Authors:  G W Smith; L I Somova
Journal:  Br J Pharmacol       Date:  1976-10       Impact factor: 8.739

10.  Attenuation by bradykinin of adrenergically-induced vasoconstriction in the isolated perfused kidney of the rabbit: relationship to prostaglandin synthesis.

Authors:  K U Malik; A Nasjletti
Journal:  Br J Pharmacol       Date:  1979-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.